7/29/2022Financial-related Company News in Brief (July 2022)

7/28/2022Cosmo and 3SBio Enter License Agreement for Winlevi in Greater China

7/28/2022June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)

7/26/2022Biotech fundraising in China Warms Up A Little in June (PharmaDJ)

7/26/2022Mobile Health Applications for Depression in China: A Systematic Revie...

7/26/2022NHSA and MOF Issues Notice to Further Implement BMI Inter-provincial M...

7/26/2022MSD and Kelun Enter Oncology Research Collaboration and License Agre...

7/26/2022Review of Chinese Hospital Drug Market in Q1/2022

7/22/2022AbbVie Terminates Early-stage Study of I-Mab's Antibody lemzoparlimab...

7/22/2022Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...

7/22/2022Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...

7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...

7/21/2022A Practical Review of the New Supporting Regulations of China's Anti-M...

7/21/2022A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...

7/21/2022Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...

7/20/2022China's Prospective Payment System: 3 Ways to Prepare

7/20/2022Official Data: Chinese Pharma Growth Slows in H1/2022

7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...

7/19/2022CDE Solicits Comments on the Draft Guidelines for Clinical Development...

7/19/2022NHSA Issues New Notice to Further Strengthen Regulation of Medical Ser...

7/18/2022Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...

7/18/2022NHC's 2021 Annual Health Sector Development Report (Full Summary)

7/18/2022How China's Big Pharma Bet Could Change Intellectual Property Game

7/15/2022China's Community Health Centers Are Losing Public Appeal

7/15/2022Chinese Leaders Pledge to Advance Reform and Reduce Public Healthca...

7/15/2022Recent Official and Executive Moves

7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg

7/14/2022China's Latest Round of Volume-Based Procurement of Drugs Further Redu...

7/14/2022Chinese Biopharma In-licensing Deals in H1/2022 (Pharmcube)

Page:63/356 Total number of articles:10671: [First][<<] [61] [62] [63] [64] [65] [>>] [End]